Brief: Ekso Bionics Reports First Quarter 2022 Results
28/04/2022 21:51
April 28 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS FIRST QUARTER 2022 RESULTS
* Q1 LOSS PER SHARE $0.36
* Q1 REVENUE $2.6 MILLION
* CASH POSITION OF $36.2 MILLION AT MARCH 31, 2022
Source text for Eikon: ID:nGNX26CMls
Further company coverage: EKSO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Soluna To Form Strategic Partnership With Applied Digital For Wind-Powered AI Data Center In Texas
Brief: Chronoscale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue To $1 Billion And Sale Of Ekso Bionics Business Unit
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
U.S. STOCKS ON THE MOVE-Veeva Systems, Dollar General, ChronoScale